DK121184A - Krystalmodifikation af ceftazidim, dens fremstilling og anvendelse - Google Patents

Krystalmodifikation af ceftazidim, dens fremstilling og anvendelse Download PDF

Info

Publication number
DK121184A
DK121184A DK121184A DK121184A DK121184A DK 121184 A DK121184 A DK 121184A DK 121184 A DK121184 A DK 121184A DK 121184 A DK121184 A DK 121184A DK 121184 A DK121184 A DK 121184A
Authority
DK
Denmark
Prior art keywords
ceftazidim
manufacturing
crystal modification
compound
preparation
Prior art date
Application number
DK121184A
Other languages
English (en)
Other versions
DK166542C (da
DK121184D0 (da
DK166542B1 (da
Inventor
Walter Duerckheimer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK121184D0 publication Critical patent/DK121184D0/da
Publication of DK121184A publication Critical patent/DK121184A/da
Application granted granted Critical
Publication of DK166542B1 publication Critical patent/DK166542B1/da
Publication of DK166542C publication Critical patent/DK166542C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
DK121184A 1983-04-16 1984-02-28 Vandfrit, krystalliseret ceftazidim, dets fremstilling og anvendelse til fremstilling af et farmaceutisk praeparat samt saadant praeparat DK166542C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833313818 DE3313818A1 (de) 1983-04-16 1983-04-16 Neue kristallmodifikation von ceftazidim

Publications (4)

Publication Number Publication Date
DK121184D0 DK121184D0 (da) 1984-02-28
DK121184A true DK121184A (da) 1984-10-17
DK166542B1 DK166542B1 (da) 1993-06-07
DK166542C DK166542C (da) 1993-10-25

Family

ID=6196561

Family Applications (1)

Application Number Title Priority Date Filing Date
DK121184A DK166542C (da) 1983-04-16 1984-02-28 Vandfrit, krystalliseret ceftazidim, dets fremstilling og anvendelse til fremstilling af et farmaceutisk praeparat samt saadant praeparat

Country Status (13)

Country Link
US (1) US4624948A (da)
EP (1) EP0122585B1 (da)
JP (1) JPH0613525B2 (da)
KR (1) KR910004333B1 (da)
AT (1) ATE40692T1 (da)
AU (1) AU571506B2 (da)
CA (1) CA1245630A (da)
DE (2) DE3313818A1 (da)
DK (1) DK166542C (da)
ES (1) ES531584A0 (da)
IE (1) IE58132B1 (da)
PT (1) PT78418B (da)
ZA (1) ZA842773B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
GB8406218D0 (en) * 1984-03-09 1984-04-11 Glaxo Group Ltd Process
US4537959A (en) * 1984-03-26 1985-08-27 Eli Lilly And Company Crystalline cephalosporin antibiotic salt
HU194179B (en) * 1985-10-03 1988-01-28 Chinoin Gyogyszer Es Vegyeszet Process for production of 1-/3',4'-dietoxi-benzil/-1,6,7-dietoxi-3,4-dihydro-izoquinolinine-teophilin-7-acetate and their new cristallic monohydrate
GB8714180D0 (en) * 1987-06-17 1987-07-22 Rifar Srl Anhydrous crystalline cefadroxil
IE61679B1 (en) * 1987-08-10 1994-11-16 Fujisawa Pharmaceutical Co Water-soluble antibiotic composition and water-soluble salts of new cephem compounds
KR100296810B1 (ko) * 1993-03-12 2001-10-24 로렌스 티. 마이젠헬더 결정성세프티오퍼유리산
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
CN106420658A (zh) * 2016-09-23 2017-02-22 临沂草之美医药科技有限公司 一种治疗外科手术感染的药物头孢他啶胶囊
CN109096309B (zh) * 2017-06-20 2019-10-01 陕西顿斯制药有限公司 一种43/4水头孢他啶化合物及其药物组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4054738A (en) * 1975-12-22 1977-10-18 Eli Lilly And Company Sodium cefamandole crystalline forms
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
HU184631B (en) * 1978-05-26 1984-09-28 Glaxo Group Ltd Process for preparing cef-3-em-4-carboxylic acid derivatives with antiaiotic activity
ZA806082B (en) * 1979-10-02 1982-05-26 Glaxo Group Ltd Cephalosphorin antibiotics
US4329453A (en) * 1979-10-02 1982-05-11 Glaxo Group Limited Cephalosporin antibiotic
DE3313816A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
US4537959A (en) * 1984-03-26 1985-08-27 Eli Lilly And Company Crystalline cephalosporin antibiotic salt

Also Published As

Publication number Publication date
DE3313818A1 (de) 1984-10-18
EP0122585B1 (de) 1989-02-08
DK166542C (da) 1993-10-25
ATE40692T1 (de) 1989-02-15
DE3476663D1 (en) 1989-03-16
US4624948A (en) 1986-11-25
DK121184D0 (da) 1984-02-28
ES8501769A1 (es) 1984-12-01
PT78418A (de) 1984-05-01
ES531584A0 (es) 1984-12-01
EP0122585A2 (de) 1984-10-24
DK166542B1 (da) 1993-06-07
KR910004333B1 (ko) 1991-06-26
JPH0613525B2 (ja) 1994-02-23
AU571506B2 (en) 1988-04-21
PT78418B (de) 1986-06-02
IE840917L (en) 1984-10-16
EP0122585A3 (en) 1985-10-16
AU2685784A (en) 1984-10-18
IE58132B1 (en) 1993-07-14
JPS59199688A (ja) 1984-11-12
ZA842773B (en) 1984-11-28
CA1245630A (en) 1988-11-29
KR840008372A (ko) 1984-12-14

Similar Documents

Publication Publication Date Title
ECSP941099A (es) Mejoras relativas a un antibiotico de cefalosporina
ES8603497A1 (es) Procedimiento para preparar derivados de cefalosporina
DK121184D0 (da) Krystalmodifikation af ceftazidim,dens fremstilling og anvendelse
SE8006860L (sv) Cefalosporinantibiotika
FI93458B (fi) Menetelmä terapeuttisesti käyttökelpoisen 7-/2-(2-aminotiatsol-4-yyli)-2-(Z)-hydroksi-iminoasetamido/-3-(metoksimetyyli)-3-kefeemi-4-karboksyylihappo-/ -(2,2-dimetyylipropionyylioksi)etyyli/esterin diastereomeerin I valmistamiseksi
DE68922629T2 (de) Ceftazidim-Dihydrochlorid-Ameisensäuresolvate.
NO902607D0 (no) Krystallinske cefemsyre-addisjonssalter og fremgangsmaate for fremstilling derav.
ES8501768A1 (es) Procedimiento para preparar (6r, 7r)-7-( (z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oximino)-acetamido)-3-(1-piridiniometil)-cef-3-em-carboxilato x 1, 5 moles de agua, cristalizado
EP0166580A3 (en) Improvements in or relating to ceftazidime
ATE31535T1 (de) Cephalosporinverbindungen.
DK536986D0 (da) Cephalosporinderivater, deres fremstilling og anvendelse
ES2043687T3 (es) Nuevo derivado cristalino de cefalosporina.
NO901418L (no) Cefalosporinderivater og deres fremstilling.
JPS6425783A (en) Novel cephalosporin compound and antibacterial material

Legal Events

Date Code Title Description
PUP Patent expired